Panel Directs Board To Reconsider Skin Cancer Patent Holding
WASHINGTON, D.C. — In a Feb. 18 ruling, the Federal Circuit U.S. Court of Appeals said the Patent Trial and Appeal Board erred in confirming as patentable two independent claims of...To view the full article, register now.
Already a subscriber? Click here to view full article